NEWS

The Biologics Manufacturing Centre (BMC) is proud to announce its participation in the Health Emergency Readiness Canada Innovation Symposium 2025 (IS2025), taking place on February 25, 2025, at the Rogers Centre in Ottawa.

This major event will bring together key leaders from the life sciences sector to discuss the latest advancements in health emergency preparedness, biopharmaceutical innovation, and biomanufacturing.

A Day of Insightful Discussions and Networking

Key highlights of IS2025 include:

• A keynote address by Dr. Mona Nemer, Canada’s Chief Science Advisor, on the 100-Day Mission and its global implications.
• Panel discussions on critical industry topics:
  • The future of health emergency preparedness
  • Next-generation technology platforms for vaccines, therapeutics, and diagnostics
  • Biomanufacturing innovation and the evolving manufacturing capacity in Canada
• Networking sessions, including rapid-fire presentations from industry stakeholders.

Isabelle Caron to Speak at IS2025

We are especially proud to announce that Isabelle Caron, President & CEO of BMC, will be joining an expert panel discussion exploring the future of health emergency preparedness and the development of biopharmaceutical infrastructure in Canada.

She will share the stage with renowned industry leaders, including:

• Philip Jennings, Deputy Minister, Innovation, Science and Economic Development Canada
• Heather Jeffrey, President, Public Health Agency of Canada
• Hamilton Bennett, Senior Director, Moderna
• Dr. Volker Gerdts, CEO, Vaccine and Infectious Disease Organization
• Dr. Carl Hansen, CEO, AbCellera
• …and many more distinguished experts.

Join Us at IS2025!

Whether you are a researcher, industry leader, or policymaker, IS2025 is a unique opportunity to connect with key players in the life sciences sector and explore the challenges and innovations shaping the future.

To learn more, click here